US.: +1-252-477-1362
UK.: +44-203-957-8553
AUS.: +61-2-4786-0457
INDIA: +91-848-285-0837
The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find... View more
The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
Market Challenges
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Combating Challenges
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patient-centricity
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Conclusion
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.View less
Published Date : Nov 2024
Global hereditary angioedema market is estimated to be valued at USD 2.86 Bn in 2024 and is expected to exhibit a CAGR of 9.4% during the forecast period (2024-2031). Hereditary angioedema is a rare genetic disorder characterized by recurrent episodes of intense subcu... View more
Published Date : Nov 2024
Global dementia drugs market is estimated to be valued at USD 24.47 Bn in 2024 and is expected to exhibit a CAGR of 6.6% during the forecast period (2024-2031). Dementia drugs market growth is driven by rising cases of Alzheimer's and other forms of dementia worldwide... View more
Published Date : Nov 2024
Global colorectal cancer therapeutics market is estimated to be valued at USD 8.98 Bn in 2024 and is expected to exhibit a CAGR of 4.3% during the forecast period (2024-2031). Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-... View more
Published Date : Nov 2024
Global small molecule injectable drugs market is estimated to be valued at USD 216.73 Bn in 2024 and is expected to exhibit a CAGR of 8.1% during the forecast period (2024-2031). The growing prevalence of chronic diseases and rising demand for targeted drug delivery s... View more
Published Date : Nov 2024
Global epilepsy drugs market is estimated to be valued at USD 10.31 Bn in 2024 and is expected to exhibit a CAGR of 5.3% during the forecast period (2024-2031). Epilepsy is a chronic non-communicable disease characterized by recurrent seizures, which are brief episode... View more
Published Date : Nov 2024
Global global chronic myeloid leukemia treatment market is estimated to be valued at USD 8.47 Bn in 2024 and is expected to exhibit a CAGR of 6.5% during the forecast period (2024-2031). Chronic myeloid leukemia (CML) is a type of cancer that starts in the bone marrow... View more
Published Date : Sep 2024
Global camylofin market offer huge opportunities for market players due to its wide range of therapeutic applications. Camylofin is a promising pharmaceutical compound that is used for treatment of anxiety, insomnia and depression. There has been increase in prevalenc... View more
Published Date : Sep 2024
Global gastroenterology market growth is driven by rising gastrointestinal disorders such as stomach ulcer, inflammatory bowel disease, irritable bowel syndrome and growing geriatric population that requires effective diagnosis and treatment solutions. Furthermore, te... View more
Published Date : Sep 2024
Bacteriostatic water for injection refers to sterile water that contains a suitable concentration of preservative to inhibit the growth of micro-organisms inoculated during its preparation or intended use. Bacteriostatic water is used in the reconstitution of powdered... View more
Published Date : Sep 2024
Prescription hair loss refers to the loss of hair from the scalp or other parts of the body that occurs due to aging, hormonal changes, medical conditions, stress or genetic predisposition. Global prescription hair loss and hair removal drugs market growth is driven p... View more
Published Date : Sep 2024
Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through life... View more
Published Date : Sep 2024
Apoptosis, commonly known as programmed cell death, is a natural process in living organisms to remove unnecessary or damaged cells in a controlled manner. Dysregulation of apoptosis can lead to pathogenic conditions like cancer, autoimmune disorders, and neurodegener... View more
Published Date : Sep 2024
Global donor egg IVF (in-vitro fertilization) market growth is driven by rising infertility rates. Donor egg IVF is an assisted reproductive technology, in which a woman's eggs are fertilized outside her body with sperm and the fertilized egg or embryo is placed in an... View more
Published Date : Aug 2024
The global Rivaroxaban market has been growing steadily over the past decade on the back of rising prevalence of deep vein thrombosis and pulmonary embolism disorders globally. Rivaroxaban is an oral anticoagulant that acts as an inhibitor of factor Xa in the blood co... View more
Published Date : Aug 2024
Multiple sclerosis (MS) is a chronic autoimmune disorder that affects the central nervous system (CNS). It is caused when the immune system attacks myelin, the protective sheath surrounding nerve fibers of the CNS. The damage disrupts communication between the brain a... View more
Published Date : Aug 2024
Ursodeoxycholic acid is a bile acid produced by the liver that helps in digestion and absorption of consumed fats. It is prescribed for treating various liver related conditions such as primary biliary cirrhosis (PBC) and gallstones. Global ursodeoxycholic acid market... View more
Published Date : Aug 2024
Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in... View more
Published Date : Aug 2024
Chronic pain is defined as any pain lasting for more than three months or past the normal time of healing. The conditions that cause chronic pain are numerous and wide-ranging from arthritis, back pain, cancer, neurological disorders and fibromyalgia among others. Sed... View more
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.